1.
Magri V, Scagnoli S, Piesco G, Pomati G. Lapatinib as second-line treatment after the double block pertuzumab-trastuzumab: a case report: Lapatinib in II linea dopo il doppio blocco pertuzumab-trastuzumab: un caso clinico. AboutOpen [Internet]. 2018 Oct. 31 [cited 2024 Nov. 23];4(1):185-90. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/131